Browse all articles >
CLOSE
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?2021 July;64(4)
Pregnancy outcome following early exposure to maternal GnRH agonist in controlled ovarian hyperstimulation.1991 December;34(12)
Clinical evaluation of severe ovarian hyperstimulation syndrome.1992 June;35(6)
The clinical value of serum 17-hydroxyprogesterone levels for predicting LH surge in controlled ovarian hyperstimulation.1993 March;36(3)
The effective of ultrashort-term gonadotropin-releasing hormone agonist administration in controlled ovarian hyperstimulation for in vitro fertilization.1993 July;36(7)